A Decade of Nintedanib: An Analysis of the FDA Adverse Event Reporting System Database

被引：0
|
作者：
Niranjan, S. [1 ]
Rao, A. [2 ]
Virk, S. T. [1 ]
Sarangdhar, M. [3 ]
机构：
[1] Allegheny Gen Hosp, Internal Med, Pittsburgh, PA USA
[2] Carnegie Mellon Univ, Quantitat Biol & Bioinformat, Pittsburgh, PA USA
[3] Univ Cincinnati, Biomed Informat, Cincinnati, OH USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3746
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib
    Wu, Yan
    Wei, Meihao
    Zhang, Jing
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [22] Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database
    Picaut, Philippe
    CLINICAL DRUG INVESTIGATION, 2018, 38 (12) : 1197 - 1198
  • [23] Mining and analysis of dizziness adverse event signals in postoperative analgesia patients based on the FDA adverse event reporting system database
    Zhou, Fengqi
    He, Haiou
    Zhang, Zhen
    Gao, Jing
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [24] Ocular adverse events of cenegermin used in neurotrophic keratopathy: an analysis of the FDA adverse event reporting system database
    Li, Yunfei
    Yang, Haiyun
    Gao, Yuan
    He, Weimin
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (03) : 385 - 391
  • [25] An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database
    Wang, Hsin-wei
    Hochberg, Alan M.
    Pearson, Ronald K.
    Hauben, Manfred
    DRUG SAFETY, 2010, 33 (12) : 1117 - 1133
  • [26] An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database
    Hsin-wei Wang
    Alan M. Hochberg
    Ronald K. Pearson
    Manfred Hauben
    Drug Safety, 2010, 33 : 1117 - 1133
  • [27] Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database
    Morris, Robert
    Ali, Rahinatu
    Cheng, Feng
    CURRENT DRUG TARGETS, 2024, 25 (07) : 454 - 464
  • [28] Adverse Effects of Clopidogrel: a Cross Sectional Study of the FDA Adverse Event Reporting System Database
    Al-Saikhan, Fahad
    Ahmad, Nehad
    Abd-Elaziz, Mohamed
    Iqbal, Muhammad Shahid
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (07): : 1388 - 1391
  • [29] Adverse event profiles of CDK4/6 inhibitors: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database
    Tian, Xiaojiang
    Chen, Lin
    Chen, Yonghong
    Zhang, Ni
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [30] Mining and analysis of adverse event signals for alendronate based on the real-world data of FDA adverse event reporting system database
    Zhao, Ziyi
    Ji, Hongxiang
    Zhang, Chenghao
    Wang, Zhengdan
    Ren, Shengquan
    Liu, Chunlei
    Wu, Caifeng
    Wang, Jian
    Ding, Xiaoheng
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (03) : 297 - 304
12345